Brief Pain Exposure Therapy for Fibromyalgia (BPET) Study

University of Michigan

Status

Enrolling

Conditions

Fibromyalgia

Treatments

Behavioral: Brief pain exposure therapy (BPET)

Study type

Interventional

Funder types

Other

Identifiers

NCT06208514

HUM00238637

Details and patient eligibility

About

This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia (such as depression or anxiety).

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Physician diagnosis of fibromyalgia (FM)
2016 American College of Rheumatology (ACR) Criteria for FM: Widespread pain index score is ≥ 7 and symptom severity scale score is ≥ 5, or widespread pain index score is 4 to 6 and symptom severity score is ≥ 9
Able to read, write and speak English
Internet access and audio-visual conferencing capability (e.g., Zoom meetings by phone or computer) in the home

Exclusion criteria

Indication of a co-occurring (non-fibromyalgia) cause of chronic pain (e.g., inflammatory arthritis, autoimmune disorders, spinal cord injury, cancer)
Currently receiving cognitive-behavioral therapy or other psychological therapies for pain
Open litigation regarding chronic pain in the past 1 year, as assessed in preliminary study screening.
Inability to provide informed consent and complete study procedures (e.g., indications of suspected major cognitive impairment via observations of study staff during consenting) that would preclude comprehension or participation in study protocols.
Pregnant or breastfeeding
Any other diseases or conditions that would make a patient unsuitable for study participation as determined by the site principal investigators.